Canada’s Valeant Pharmaceuticals has struck a deal with AstraZeneca of the U.K. to develop and sell psoriasis treatment brodalumab.
Weakness in Chinese manufacturing activity could be temporary, but it is clear that the formerly high-revving economy is now missing on some cylinders.
The firm told investors it lost 5.3% in August as the value of its major holdings declined, said people familiar with the matter, widening its loss for the year to 13.8%.
South Korea said exports posted their sharpest fall in six years in August as shipments slumped to China.
Chinese developer Evergrande’s performance may not be as grand as it seems.
A federal regulator’s campaign to fight bias against minorities is changing the way many car loans are priced, a move that is increasing costs for some consumers.
Branding firm Red Antler is among vendors that are looking to profit on the soaring valuations of young startups by taking payment in stock instead of cash.
Warren Buffett’s investment in Phillips 66 looks like it might be another instance of him buying in at the peak of the market. Think again.
Speculation that a pro-investor settlement looms in the Fannie Mae and Freddie Mac cases has driven shares sharply higher. This is wishful thinking.
Ahead of the Tape: A record number of leased vehicles may soon weigh on new-car sales growth.